Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Genprex Inc has a consensus price target of $6.5 based on the ratings of 2 analysts. The high is $10 issued by HC Wainwright & Co. on May 17, 2024. The low is $3 issued by Dawson James on January 30, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 17, 2024, May 15, 2024, and April 4, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 1049.43% upside for Genprex Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Genprex (NASDAQ:GNPX) was reported by HC Wainwright & Co. on May 17, 2024. The analyst firm set a price target for $10.00 expecting GNPX to rise to within 12 months (a possible 1049.43% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Genprex (NASDAQ:GNPX) was provided by HC Wainwright & Co., and Genprex reiterated their buy rating.
There is no last upgrade for Genprex
There is no last downgrade for Genprex.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genprex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genprex was filed on May 17, 2024 so you should expect the next rating to be made available sometime around May 17, 2025.
While ratings are subjective and will change, the latest Genprex (GNPX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Genprex (GNPX) is trading at is $0.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.